#TSP Advanced Technologies @TruSpinePlc notice of AGM ✅️ To be held at 11am on Dec 10 2025 at Regus Crawley, Gatwick Airport Manor Royal, Churchill Court 3, Crawley, RH10 9LU https://t.co/GllzpRbGNm

Quoted Micro 17 November 2025 - #THW #MDH #AAI #HRIP #ANA #WCAP #EDGE #VLRM #SWC #ETHY #WSBN #V3TC #HODL #DXSP #BWAP #NGHT #TSTR #SALT #TEAM #WHI #SWG #CRS #ROAD #HVO #AMRQ #GFIN #CNSL #LORD #TENG #GDP #APTA #BUCC #PTAL #RCFX #POLX #TIME #EMR #LUCE #NFM #GEX @Hubinvest

A reminder that our team will be attending this week's London Life Sciences Week! We invite you to connect with Poolbeg Pharma via the PartneringOne platform to arrange a meeting. This is an excellent opportunity to exchange insights, explore potential collaborations, and learn

The UK Government’s Life Sciences Sector Plan 2025 marks a bold step toward making the UK a global leader in health and biomedical innovation. With over £2 billion in new investment and a 10-year vision, the plan aims to: ✅ Accelerate clinical research and innovation ✅

Insightful @FT piece on China's control of 88% of refined #rareearths & nearly half of reserves. US, EU & others are racing to diversify supply, invest in recycling & alternatives but reducing China’s dominance will take years of strategy & coordination https://t.co/a8fuQUw85g

On today's @StockBoxMedia #podcast, @Alan__Green @Brand_UK @BrandMultiComms @NovusComms & @danielflynn92 @Outofthegr discuss: ✅ @UruMetals #URU ✅ @CriticalMinRes #CMR ✅ @onehealthgroup #OHGR ✅ @MedPalPlc #MPAL with @MarkEJFairbairn #nickel #zebnickel @IvanhoeMines_

A reminder that our Chief Executive Officer Yamin Mo Khan will be presenting in-person at the Jefferies Global Healthcare Conference in London on 20 November 2025 at 12:30pm. hVIVO will be available for one-to-one meetings throughout the conference, get in touch to schedule a

hVIVO was featured in a @ShareTalkNews article which highlights hVIVO's diversification strategy following the launch of multiple new service lines and the strategic acquisitions of CRS and Cryostore, which has created an integrated full-service early phase CRO which can provide

#BRES @BlencoweRes – Warrant Exercise ✅ 1,666,666 warrants @ 4.5p exercised, raising £75,000 ➡️ 1,666,666 new shares to be issued Board: “Warrant exercises since Oct now total ~£550k, supporting DFS completion and project financing discussions.” read- https://t.co/JNgSwgmiIG

#MDH - Good to see industry publishers picking up the @MendellHelium story. Rost well now in production, with #helium and NGL output increasing steadily day on day. Add this to completion of the @M3Helium acquisition and the move to AIM.... oh and the farm-in agreement with

Our CSO Andrew Catchpole was featured in an interview at @vaccinenation's The World Vaccine Congress in Amsterdam The highlights: 👉🔬 First-to-market RSV-B challenge model 💡 Supporting developers from preclinical to early-phase trials 🎯 Streamlining drug development timelines

The team have been busy with conference season in full swing. Our CEO Jeremy Skillington & Principal Scientist Liam Tremble caught up with @zakmir on @ShareTalkNews on their thoughts about the recent conferences & what's next on Poolbeg's radar. ☑️ESMO Conference key take aways

EGT’s 100%-owned Olserum Project in #Sweden could become Europe’s only active #REE mine, supporting the #EU’s Critical Raw Materials Act & energy transition Consistent mineralisation ✅ High-grade concentrates ✅ Well established infrastructure✅ https://t.co/L72aM3oy9Y #EGT

Check out our latest #factsheet ✅Investment case ✅Key acquisition criteria ✅Current #EU assets ✅Leadership team with strong track record #EGT is seeking to acquire and transform distressed, revenue generating #businesses across a range of sectors https://t.co/bCl3ZsHgyi

hMPV is not a new virus. Learn more about how this virus was discovered by one of the hMPV founding fathers Professor Guy Boivin. In this highlight video of our Chief Scientific Officer, Dr Andrew Catchpole is back with Guy to discuss why it might have taken some time to identify

Our lead candidate, POLB 001, continues to make impressive progress as a potential breakthrough in preventing Cytokine Release Syndrome (CRS) — a dangerous inflammatory reaction seen with advanced cancer immunotherapies like CAR-T and bispecific antibodies. Check out our new

Our Chief Scientific Officer caught up with @proactive_x on this mornings announcement, highlighting the recent positive results from our human challenge models. 👉Overview of key conferences ESWI & WVC EU ✅The world's only contemporary-strain hMPV human challenge model

#HVO hVIVO PLC - Positive data from novel human challenge models - It shared positive data from new human challenge models. - The results show strong capability and readiness to meet rising demand for innovative clinical trial solutions. https://t.co/ZRVJ0yEmkh

We presented positive data from a number of newly development human challenge models at leading scientific conferences @ESWInfluenza & the @vaccinenation World Vaccine Congress Europe. 🔬 hMPV Challenge Model – The world’s only contemporary-strain hMPV challenge model, now ready

#MDH @MendellHelium - Helium Production commences at Rost ✅ Commercial production commences, and flow rates continue to increase in significant increments each day as de-watering progresses ✅ Well now producing in excess of 100 Mcf per day of total gas (over $1,600 of #helium